Kite Pharma and Cell Design Labs said today they will partner to develop next-generation, precision-controlled chimeric antigen receptor (CAR) T-cell immunotherapy candidates using Cell Design Labs’ ...
SANTA MONICA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Kite Pharma, Inc. (NASDAQ: KITE) (“Kite”) and Cell Design Labs, Inc. today announced a research collaboration and license agreement to develop ...
Gilead Sciences and its Kite cell therapy subsidiary have agreed to acquire Cell Design Labs for up to approximately $567 million, in a deal designed to grow the buyers’ footprint in chimeric antigen ...
Aecon and Skyport are launching a contest to design Bermudian kites, with the winning designs set to “be incorporated into actual kites that will be suspended from the ceilings in the new terminal.” ...
CC0 Usage Conditions ApplyClick for more information. Why? This kite system harnesses the winds energy with a tethered wing that flies at high altitudes where the wind is both strong and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results